Loading...
Loading...
ATRC| Name | Value |
|---|---|
| Revenues | 115.9M |
| Cost of Revenue | 29.1M |
| Gross Profit | 86.8M |
| Operating Expense | 94.2M |
| Operating I/L | -7.4M |
| Other Income/Expense | -0.1M |
| Interest Income | 1.3M |
| Pretax | -7.5M |
| Income Tax Expense | 0.3M |
| Net Income/Loss | -7.9M |
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue and intercostal nerves to medical centers globally. Its product line includes Isolator Synergy Clamps, multifunctional pens, linear ablation devices, Coolrail device, cryoICE Cryoablation System, EPi-Sense Guided Coagulation System, AtriClip System, and LARIAT System. The company also offers Lumitip Dissectors, Glidepath guides, Subtle Cannula's, and reusable cardiac surgery instruments. AtriCure generates revenue by marketing and selling its products through independent distributors and direct sales personnel, catering to the needs of medical professionals and healthcare facilities worldwide.
